Clinical outcomes of HIV-infected patients hospitalized with community-acquired pneumonia: Results from CAPO international cohort study Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia Year: 2010
Risk factors for community-acquired pneumonia in hospitalized adult patients, a case-control study Source: Eur Respir J 2006; 28: Suppl. 50, 351s Year: 2006
Management of community-acquired pneumonia in primary care: an observational study Source: International Congress 2019 – Treatment of airway diseases in primary care Year: 2019
The presence of diabetes does not influence clinical outcomes in patients with community-acquired pneumonia: results from the community-acquired pneumonia organization (CAPO) international cohort study Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia Year: 2007
Community-acquired pneumonia. Prospective inpatient study Source: Eur Respir J 2004; 24: Suppl. 48, 414s Year: 2004
Mortality directly related to community-acquired pneumonia (CAP) in hospitalized patients: results from the community-acquired pneumonia organization (CAPO) international cohort study Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007
The impact of hyperglycemia on community-acquired pneumonia: A retrospective cohort study Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016
The impact of adherence to guidelines for hospitalized community-acquired pneumonia on health outcomes and mortality: A retrospective cohort study Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015
Etiology of community-acquired pneumonia requiring hospitalization in Chile: a prospective study Source: Eur Respir J 2005; 26: Suppl. 49, 255s Year: 2005
Community-acquired pneumonia in the elderly: Spanish multicentre study Source: Eur Respir J 2003; 21: 294-302 Year: 2003
Retrospective analysis of clinical data of 315 hospitalized patients with community-acquired pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 415s Year: 2004
Community-acquired pneumonia in the elderly: Spanish multicentre study Source: Eur Respir J 2001; 18: Suppl. 33, 189s Year: 2001
Significant decrease in long-term survival for hospitalised patients with community-acquired pneumonia (CAP): results from the community-acquired pneumonia organisation (CAPO) international cohort study Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia Year: 2009
Comparative analysis of clinical and epidemiological characteristics of patients with CAP (community-acquired pneumonia) treated as inpatients and outpatients Source: Eur Respir J 2006; 28: Suppl. 50, 3s Year: 2006
Thrombocytosis predicts poor outcomes in patients with community-acquired pneumonia: results from the CAPO international cohort study Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections Year: 2008
Bacteriological diagnosis in hospitalized community-acquired pneumonia (HCAP): an eighteen-month study Source: Eur Respir J 2001; 18: Suppl. 33, 541s Year: 2001
The extent of microbiological testing and antibiotic de-escalation in adults with community-acquired pneumonia: a retrospective cohort study. Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection Year: 2018
Do not resuscitat orders in community-acquired pneumonia: a restrospective cohort study. Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers Year: 2017
Risk factors (RF) for community-acquired pneumonia (CAP) in adults. A population-based case-control study Source: Eur Respir J 2002; 20: Suppl. 38, 419s Year: 2002
Impact of bacteremia in a cohort of predominantly elderly patients with pneumococcal pneumonia. Epidemiologic and case-control study Source: Eur Respir J 2002; 20: Suppl. 38, 354s Year: 2002